Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Karen Ingrid Schreiber
High Treatment Adherence, Satisfaction, Motivation, and Health-Related Quality of Life With Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis &Ndash; Results From a 24-Month, Multicenter, Open-Label Danish Study
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Related publications
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study
Multiple Sclerosis International
Neurology
Pnd116 - A Three Month Interim Analysis of Fingolimod Treatment Adherence for Relapsing Remitting Multiple Sclerosis in the Uk: The Patient Reported Outcomes With Fingolimod in Local Experience (Profile) Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment of Remitting-Relapsing Multiple Sclerosis (MS) With Cladribine: Results of an Open Pilot Study at 18 Months
Journal of Neurology
Neurology
Treatment Satisfaction and Quality of Life in Patients Treated With Fingolimod
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Health State Utilities in Patients With Relapsing Remitting Multiple Sclerosis Treated With Cladribine Tablets
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis
Arquivos de Neuro-Psiquiatria
Biological Psychiatry
Neurology
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients With Relapsing Forms of Multiple Sclerosis (MANAGE)
International Journal of MS Care
Neurology
Specialized Nursing
Advanced
The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study
PLoS ONE
Multidisciplinary
